- Life Sciences - 10:00 Predicting people’s ’brain age’ could help to spot who is at risk of early death
- Medicine - 10:00 Six ways Imperial researchers are working to eliminate malaria
- Business - 08:00 Novartis delivered sales growth across all divisions (cc1) as growth drivers, including Cosentyx and Entresto, more than offset generic erosion; innovation momentum continued
- Social Sciences - Apr 24 Prenatal screening for Down’s syndrome seen as ‘routine practice’
- Medicine - Apr 24 Family caregivers help with wider range of healthcare tasks than thought
- Medicine - Apr 24 Electrical engineer puts sweat tech to the test
- Medicine - Apr 24 Yale‘s Dr. Patrick O’Connor partners with experts to address TV portrayals of addiction
- Medicine - Apr 24 Tiny ‘cages’ to keep vaccine supplies safe
- Medicine - Apr 24 Novartis real- world data at AAN confirms benefit of Gilenya on four key measures of disease activity in relapsing MS
- Medicine - Apr 24 Novartis expands global collaboration with Amgen to commercialize first-in- class AMG 334 (erenumab) program in migraine prevention in the US and Canada
- Medicine - Apr 24 ’In the Moment’ at TEDxStanford
- Medicine - Apr 24 Ideas sought for long- range planning process
- Environment - Apr 21 Earth day: Imperial event brings together experts to tackle air pollution
- Medicine - Apr 21 Yale experts offer thoughts on ‘Science Under Siege’
- Life Sciences - Apr 21 NIH Awards Team $7 Million for Autism Genetics Research
- Medicine - Apr 21 Senior salsa brings home the power of staying active
Researchers put the squeeze on citrus disease by developing trees that taste bad to bugs
With Florida’s $9 billion citrus industry threatened by a deadly bacterial disease, Rick Kress ’73 asked scientists at Cornell’s New York State Agricultural Experiment Station in Geneva for help. Three years later, the researchers have delivered several genetically engineered orange trees that could provide a long-term solution.
The trees were engineered to provide a natural resistance to the Asian citrus phyllid, the insect responsible for spreading the deadly bacterial disease huanglongbing -- also known as citrus greening because it causes perpetually immature green fruit that tastes bitter, medicinal and sour. First confirmed in Florida in 2005, the disease has spread to all citrus growing counties, and growers face a costly regime of cutting out dying trees and spraying insecticides to reduce the psyllid populations.
Far from the citrus growing climate and the federally quarantined psyllid pest, Cornell scientists turned to a model system instead: tomatoes.
Plant pathology and plant-microbe biology faculty members Kerik Cox and Herb Aldwinckle first identified a handful of naturally occurring insecticides produced by bacteria, fungi and plants known to fend off other types of insects.
Research support specialist Ewa Borejsza-Wysocka and technicians Peggy Abbott and Shirley Kuehne then used genetic engineering to insert candidate genes individually and in groups into tomato plants. They found some transgenic lines were very effective in making the tomato leaves unappealing to tomato psyllid insects and inserted the most promising genes into the Hamlin orange variety.
The diminutive transgenic orange plants await the opportunity to prove themselves against the Asian citrus psyllid on its home turf in Florida while the required permits and approvals are being secured. Aldwinkle said that he hopes to have some results of the trials within a year.
Kress, president of Southern Gardens Citrus Inc., one of the largest citrus growers and processors of not-from-concentrate orange juice in Florida, is in the process of continuing the overall research in Florida through evaluation of disease resistance on a commercial basis. He is optimistic that the work will have tremendous economic benefits. "It would also have a positive environmental impact by reducing insecticide sprays, because in Florida, trying to eliminate the Asian citrus psyllid is as daunting as trying to get rid of mosquitoes," Kress said.
Amanda Garris is a freelance writer in Geneva, N.Y.
Last job offers
- Medicine/Pharmacology - 18.4
Professeur-e ordinaire ou associé-e, médecin-chef-fe du service de médecine interne de réhabilitation...
- Chemistry - 18.4
Doktorand/in Funktionelle Materialien
- Medicine/Pharmacology - 15.4
Chargé-e de cours à 40% dans le domaine neuro-musculaire
- Life Sciences - 15.4
Wissenschaftliche/r Mitarbeiter/in 60%
- Environment - 21.3
Leiter/in der Forschungsgruppe Vegetationsökologie
- Medicine/Pharmacology - 21.3
Dozentin / Dozenten für Pharmakologie und Pharmatechnologie mit Fachgruppenleitung
- Life Sciences - 24.4
Lecturer, Microbiology, School of Science and Health
- Medicine/Pharmacology - 24.4
899615 Clinical Professor of Cardiology